Homocysteine and cardiovascular disease

Area of Science:

• Cardiovascular Research
• Metabolic Health
• Thrombosis Studies

Background:

• Elevated homocysteine is strongly associated with atherothrombotic disease and venous thromboembolism.
• This association is particularly noted in coronary disease.
• Screening may be beneficial for unexplained thrombotic tendencies and young patients with premature coronary events.

Purpose of the Study:

• To review the association between homocysteine levels and cardiovascular and thrombotic diseases.
• To explore the potential benefits of lowering homocysteine in high-risk individuals.
• To discuss methods for homocysteine reduction and their impact on atherosclerosis.

Main Methods:

• Literature review of research over the past decade.
• Analysis of emerging data on hyperhomocysteinemia and cardiac disease.
• Examination of preliminary studies on homocysteine-lowering interventions.

Main Results:

• Hyperhomocysteinemia is linked to various atherothrombotic conditions.
• Lowering homocysteine, through diet or supplements (folic acid, B vitamins), may be beneficial.
• Preliminary data suggest slowing of atherosclerosis progression in coronary and carotid vessels.

Conclusions:

• While causality is not yet proven, lowering homocysteine shows promise for managing atherothrombotic disease.
• Safe and inexpensive methods exist to reduce homocysteine levels.
• Further trials are needed to confirm mortality benefits.